T Konatschnig1, A Knöll, A Hug, W Hacke, P Ringleb. 1. Neurologische Klinik der Ruprecht Karls-Universität Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland. Thomas.Konatschnig@med.uni-heidelberg.de
Abstract
BACKGROUND: About 1,300 stroke patients from a primarily rural area are treated each year at the Department of Neurology of the University Hospital of Heidelberg, Germany. Demographic and treatment data of all stroke patients there were prospectively collected. In a retrospective study we report on the changes in this patient population from 1996 to 2006, with special consideration of those suitable for intravenous thrombolysis. METHODS: For all stroke patients the basic data were collected--age, sex, type of stroke (transient ischemic attack, stroke, or intracerebral hemorrhage), NIH Stroke Scale, duration between symptom onset and hospital arrival, delay between arrival and first doctor's contact, patient's further whereabouts, and for patients treated by iv thrombolysis, start of treatment and dosage. RESULTS: There were no changes in the total number of stroke patients and median stroke severity, according to the NIH Stroke Scale, from 1996 to 2006. The proportion of stroke patients admitted within the first 3 h after symptom onset increased from 12.1% (1996) to 21.9% (2006). Thus we managed to treat 10.1% of all our ischemic stroke patients with iv thrombolysis, which means 39% of those patients with cerebral infarction arriving within 3 h. DISCUSSION: During the study period there were no significant changes in the patients' sociodemographic data. By consistent reduction of prehospital delay, the number of stroke patients that could be treated acutely by intravenous thrombolysis was increased.
BACKGROUND: About 1,300 strokepatients from a primarily rural area are treated each year at the Department of Neurology of the University Hospital of Heidelberg, Germany. Demographic and treatment data of all strokepatients there were prospectively collected. In a retrospective study we report on the changes in this patient population from 1996 to 2006, with special consideration of those suitable for intravenous thrombolysis. METHODS: For all strokepatients the basic data were collected--age, sex, type of stroke (transient ischemic attack, stroke, or intracerebral hemorrhage), NIH Stroke Scale, duration between symptom onset and hospital arrival, delay between arrival and first doctor's contact, patient's further whereabouts, and for patients treated by iv thrombolysis, start of treatment and dosage. RESULTS: There were no changes in the total number of strokepatients and median stroke severity, according to the NIH Stroke Scale, from 1996 to 2006. The proportion of strokepatients admitted within the first 3 h after symptom onset increased from 12.1% (1996) to 21.9% (2006). Thus we managed to treat 10.1% of all our ischemic strokepatients with iv thrombolysis, which means 39% of those patients with cerebral infarction arriving within 3 h. DISCUSSION: During the study period there were no significant changes in the patients' sociodemographic data. By consistent reduction of prehospital delay, the number of strokepatients that could be treated acutely by intravenous thrombolysis was increased.
Authors: Dawn Kleindorfer; Joseph Broderick; Jane Khoury; Matthew Flaherty; Daniel Woo; Kathleen Alwell; Charles J Moomaw; Alexander Schneider; Rosie Miller; Rakesh Shukla; Brett Kissela Journal: Stroke Date: 2006-08-31 Impact factor: 7.914
Authors: Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren Journal: Lancet Date: 2007-01-27 Impact factor: 79.321
Authors: Martin Köhrmann; Eric Jüttler; Jochen B Fiebach; Hagen B Huttner; Stefan Siebert; Christian Schwark; Peter A Ringleb; Peter D Schellinger; Werner Hacke Journal: Lancet Neurol Date: 2006-08 Impact factor: 44.182
Authors: P L Kolominsky-Rabas; C Sarti; P U Heuschmann; C Graf; S Siemonsen; B Neundoerfer; A Katalinic; E Lang; K G Gassmann; T R von Stockert Journal: Stroke Date: 1998-12 Impact factor: 7.914
Authors: Philippa C Lavallée; Elena Meseguer; Halim Abboud; Lucie Cabrejo; Jean-Marc Olivot; Olivier Simon; Mikael Mazighi; Chantal Nifle; Philippe Niclot; Bertrand Lapergue; Isabelle F Klein; Eric Brochet; Philippe Gabriel Steg; Guy Lesèche; Julien Labreuche; Pierre-Jean Touboul; Pierre Amarenco Journal: Lancet Neurol Date: 2007-11 Impact factor: 44.182
Authors: Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton Journal: Lancet Date: 2004-03-06 Impact factor: 79.321
Authors: J Schenkel; C Weimar; T Knoll; R L Haberl; O Busse; G F Hamann; H-C Koennecke; H-C Diener Journal: J Neurol Date: 2003-03 Impact factor: 4.849
Authors: P M Rothwell; M F Giles; E Flossmann; C E Lovelock; J N E Redgrave; C P Warlow; Z Mehta Journal: Lancet Date: 2005 Jul 2-8 Impact factor: 79.321